Pfizer’s Braftovi Combo Wins FDA Approval
The U.S. Food and Drug Administration has granted full approval to Pfizer’s BRAFTOVI (encorafenib) in combination with cetuximab and fluorouracil-based chemotherapy…
Browsing Tag